Patent · US Expired

Method to regulate CD40 signaling

US6132978A · kind A · utility

11Cited by
3References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 19, 1996
Grant dateOct 17, 2000
Priority date
Expiry dateDec 19, 2016

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2500/10
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention relates to methods useful for identifying compounds capable of specifically controlling CD40 regulation of JNK or p38 activity useful for inhibiting immunoglobulin heavy chain class switching, cytokine production and activation of cells involved in an inflammatory response. The present invention also includes kits to perform such assays and methods to control disease related to such responses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.